Published in Learn Mem on September 25, 2007
Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev (2012) 1.94
Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A (2012) 1.77
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology (2010) 1.51
Impaired extinction retention in adolescent rats: effects of D-cycloserine. Neuropsychopharmacology (2010) 1.45
From resilience to vulnerability: mechanistic insights into the effects of stress on transitions in critical period plasticity. Front Psychiatry (2013) 1.01
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Fear conditioning and extinction across development: evidence from human studies and animal models. Biol Psychol (2014) 0.96
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92
Factors governing single-trial contextual fear conditioning in the weanling rat. Behav Neurosci (2009) 0.91
A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS One (2009) 0.87
Morphology and dendritic maturation of developing principal neurons in the rat basolateral amygdala. Brain Struct Funct (2014) 0.83
Postnatal maturation of GABAergic modulation of sensory inputs onto lateral amygdala principal neurons. J Physiol (2015) 0.80
Developmental rodent models of fear and anxiety: from neurobiology to pharmacology. Br J Pharmacol (2014) 0.80
Neuronal activity causes rapid changes of lateral amygdala neuronal membrane properties and reduction of synaptic integration and synaptic plasticity in vivo. J Neurosci (2011) 0.79
Extinction, reacquisition, and rapid forgetting of eyeblink conditioning in developing rats. Learn Mem (2014) 0.79
Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats. J Neurosci (2015) 0.76
Mothers do it differently: reproductive experience alters fear extinction in female rats and women. Transl Psychiatry (2016) 0.75
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol (2005) 4.03
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance. Mod Pathol (2012) 4.00
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med (2015) 3.60
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci (2003) 2.39
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry (2008) 2.03
Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer (2011) 1.98
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial. Lancet Oncol (2012) 1.98
Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction. J Neurosci (2011) 1.77
D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci (2004) 1.75
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res (2011) 1.69
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer (2007) 1.68
Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. Neuropsychopharmacology (2009) 1.58
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. Clin Cancer Res (2006) 1.53
Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem (2005) 1.52
Impaired extinction retention in adolescent rats: effects of D-cycloserine. Neuropsychopharmacology (2010) 1.45
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res (2006) 1.44
A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther (2006) 1.44
New findings on extinction of conditioned fear early in development: theoretical and clinical implications. Biol Psychiatry (2009) 1.40
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer. BMC Cancer (2008) 1.38
Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch (2010) 1.34
Erasing fear memories with extinction training. J Neurosci (2010) 1.33
Reinstatement of fear to an extinguished conditioned stimulus: two roles for context. J Exp Psychol Anim Behav Process (2002) 1.32
Fear extinction across development: the involvement of the medial prefrontal cortex as assessed by temporary inactivation and immunohistochemistry. J Neurosci (2009) 1.32
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer (2012) 1.31
Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem (2007) 1.28
Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT. Neuroimage (2005) 1.25
Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med (2007) 1.25
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett (2008) 1.23
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer (2011) 1.22
The effect of temporary amygdala inactivation on extinction and reextinction of fear in the developing rat: unlearning as a potential mechanism for extinction early in development. J Neurosci (2008) 1.21
Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats. Cereb Cortex (2010) 1.15
A developmental dissociation in reinstatement of an extinguished fear response in rats. Neurobiol Learn Mem (2007) 1.11
A developmental dissociation of context and GABA effects on extinguished fear in rats. Behav Neurosci (2007) 1.11
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker. BMC Cancer (2008) 1.11
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment. J Neurooncol (2011) 1.11
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer. Jpn J Clin Oncol (2008) 1.10
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat (2008) 1.09
Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial. J Affect Disord (2012) 1.07
Maternal separation results in early emergence of adult-like fear and extinction learning in infant rats. Behav Neurosci (2011) 1.03
Extinction in the developing rat: an examination of renewal effects. Dev Psychobiol (2007) 1.01
From resilience to vulnerability: mechanistic insights into the effects of stress on transitions in critical period plasticity. Front Psychiatry (2013) 1.01
D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology (2008) 1.01
Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. J Neurooncol (2010) 1.00
Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear. Neuropsychopharmacology (2010) 1.00
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2012) 0.99
A survey of sleep deprivation patterns and their effects on cognitive functions of residents and interns in Korea. Sleep Med (2011) 0.98
Task positive and default mode networks during a parametric working memory task in obstructive sleep apnea patients and healthy controls. Sleep (2011) 0.98
The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum (2011) 0.98
Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage (2005) 0.97
Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol (2004) 0.97
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. Int J Radiat Oncol Biol Phys (2010) 0.96
Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat (2008) 0.96
Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers. Breast Cancer Res (2010) 0.96
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy. J Cancer Res Clin Oncol (2011) 0.95
Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine. Biol Psychiatry (2007) 0.95
Pharmacological dissociation of trace and long-delay fear conditioning in young rats. Neurobiol Learn Mem (2006) 0.95
Memory retrieval before or after extinction reduces recovery of fear in adolescent rats. Learn Mem (2013) 0.95
Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients. Thromb Haemost (2011) 0.95
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer. Cancer Chemother Pharmacol (2009) 0.95
Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53. J Neurooncol (2010) 0.94
Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer (2014) 0.94
Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Ann Hematol (2012) 0.93
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer. Jpn J Clin Oncol (2008) 0.93
Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer. Cancer Sci (2012) 0.93
Mechanisms underpinning effective peer support: a qualitative analysis of interactions between expert peers and patients newly-diagnosed with bipolar disorder. BMC Psychiatry (2012) 0.92
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Mod Pathol (2011) 0.92
The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer (2013) 0.91
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less. BMC Cancer (2010) 0.91
Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol (2003) 0.91
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials. Int J Radiat Oncol Biol Phys (2012) 0.91
US habituation, like CS extinction, produces a decrement in conditioned fear responding that is NMDA dependent and subject to renewal and reinstatement. Neurobiol Learn Mem (2010) 0.91
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer (2004) 0.91
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy. BMC Cancer (2011) 0.90
Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery (2002) 0.90
Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain (2005) 0.90
Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy. J Korean Med Sci (2009) 0.90
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer Chemother Pharmacol (2013) 0.90
Mentalising music in frontotemporal dementia. Cortex (2012) 0.89
Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Res (2004) 0.89
Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res (2008) 0.89
Fibroblast growth factor-2 alters the nature of extinction. Learn Mem (2011) 0.89
Recovery of fear memories in rats: role of gamma-amino butyric acid (GABA) in infantile amnesia. Behav Neurosci (2006) 0.89
The prognostic value of the nodal ratio in N1 breast cancer. Radiat Oncol (2011) 0.88
Early-life exposure to fibroblast growth factor-2 facilitates context-dependent long-term memory in developing rats. Behav Neurosci (2010) 0.88
Differential involvement of the medial prefrontal cortex in the expression of learned fear across development. Behav Neurosci (2012) 0.87
Anaplastic thyroid carcinoma initially presented with abdominal cutaneous mass and hyperthyroidism. Korean J Intern Med (2010) 0.87
Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol (2014) 0.87
Resection extent versus postoperative outcomes of seizure and memory in mesial temporal lobe epilepsy. Seizure (2005) 0.87
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy. Oncology (2012) 0.86
Extinction in preweanling rats does not involve NMDA receptors. Neurobiol Learn Mem (2010) 0.86
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer. Jpn J Clin Oncol (2005) 0.86
Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes. Med Oncol (2010) 0.86
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival. Gastric Cancer (2012) 0.85